1696 — Sisram Medical Share Price
0.000.00%
Last trade - 00:00- HK$1.63bn
- HK$1.56bn
- $359.29m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 4.28 | ||
| PEG Ratio (f) | 0.16 | ||
| EPS Growth (f) | 37.76% | ||
| Dividend Yield (f) | 5.16% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.46 | ||
| Price to Tang. Book | 1.1 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 0.58 | ||
| EV to EBITDA | 3.66 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 7.61% | ||
| Return on Equity | 7.13% | ||
| Operating Margin | 11.13% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 173.52 | 162.09 | 294.29 | 354.48 | 359.29 | 408.71 | 477 | 18.48% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | -4.78 | -37.25 | +133.86 | +24.74 | -21.85 | +41.24 | +31.58 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Sisram Medical Ltd is an investment holding company principally engaged in the design, development, manufacture and distribution of energy cosmetic medicine and minimally invasive medical cosmetic treatment systems. The Company has a comprehensive medical cosmetic equipment portfolio, including medical beauty product line and life beauty product line, can be used for noninvasive medical cosmetic treatment, such as hair removal, rejuvenation, skin care, vascular treatment and pigmented lesions treatment, removal of tattoos, acne Treatment, fat reduction, body shaping and firming. The Company's medical cosmetic equipment can also be used for minimally invasive medical cosmetic treatment, such as private beauty treatment, laser liposuction, treatment of varicose veins and treatment of hyperhidrosis. The company sells its products in domestic and foreign markets.
Directors
- Yi Liu CHM (46)
- Lior Moshe Dayan CEO (48)
- Guojun Bu CFO (43)
- Ran Ezioni COO
- Doron Yannai VFN (57)
- Nadav Bayer VPR (59)
- Alexander Britva VPR (62)
- Yair Leopold VPR (63)
- Yosef Lepzelter VPR (62)
- Avraham Farbstein OTH (63)
- Fang Qianli SEC (28)
- Rongli Feng NED (44)
- Yao Wang NED (48)
- Yifang Wu NED (48)
- Chi Fung Chan NID (40)
- Jenny Chen NID (38)
- Heung Sang Fong NID (61)
- Kai Yu Liu NID (49)
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- April 25th, 2013
- Public Since
- September 19th, 2017
- No. of Employees
- 1,080
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- Stock Exchange of Hong Kong Limited
- Shares in Issue
- 468,343,092
- Address
- OFEK 15 Building, CAESAREA, 3079895
- Web
- https://sisram-medical.com/
- Phone
- +972 46275357
- Auditors
- Ernst & Young CPA
Upcoming Events for 1696
Similar to 1696
Acotec Scientific Holdings
Stock Exchange of Hong Kong Limited
Beijing Airdoc Technology Co
Stock Exchange of Hong Kong Limited
AK Medical Holdings
Stock Exchange of Hong Kong Limited
AMCO United Holding
Stock Exchange of Hong Kong Limited
Angelalign Technology
Stock Exchange of Hong Kong Limited
FAQ
What is the Sisram Medical share price?
As of Today at 19:20 UTC, shares in Sisram Medical are trading at HK$3.47. This share price information is delayed by 15 minutes.
How has the Sisram Medical share price performed this year?
Shares in Sisram Medical last closed at HK$3.47 and the price had moved by -76.33% over the past 365 days. In terms of relative price strength the Sisram Medical share price has underperformed the FTSE Developed Asia Pacific Index by -76.17% over the past year.
What are the analyst and broker recommendations for Sisram Medical?
The overall consensus recommendation for Sisram Medical is Buy. You can view the full broker recommendation list by unlocking its StockReport.
What is the Sisram Medical dividend yield?
The Sisram Medical dividend yield is 4.57% based on the trailing twelve month period.
Does Sisram Medical pay a dividend?
Last year, Sisram Medical paid a total dividend of $0.02, and it currently has a trailing dividend yield of 4.57%. We do not have any data on when Sisram Medical is to next pay dividends.
When does Sisram Medical next pay dividends?
We do not have data on when Sisram Medical is to next pay dividends. The historic dividend yield on Sisram Medical shares is currently 4.57%.
How do I buy Sisram Medical shares?
To buy shares in Sisram Medical you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Sisram Medical?
As of the previous close price of HK$3.47, shares in Sisram Medical had a market capitalisation of HK$1.63bn.
Where are Sisram Medical shares listed?
Here are the trading details for Sisram Medical:
- Country of listing: Hong Kong
- Exchange: HKG
- Ticker Symbol: 1696
What kind of share is Sisram Medical?
Based on an overall assessment of its quality, value and momentum Sisram Medical is currently classified as a Contrarian. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Sisram Medical share price forecast for 2024?
The analyst consensus target price for shares in Sisram Medical is HK$8.07. That is 132.65% above the last closing price of HK$3.47.
Analysts covering Sisram Medical currently have a consensus Earnings Per Share (EPS) forecast of $0.10 for the next financial year.
What is the trend in the Sisram Medical share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Sisram Medical. Over the past six months, its share price has underperformed the FTSE Developed Asia Pacific Index by -49.25%.
As of the last closing price of HK$3.47, shares in Sisram Medical were trading -40.77% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Sisram Medical PE Ratio?
The Sisram Medical PE ratio based on its reported earnings over the past 12 months is 4.28. The shares last closed at HK$3.47.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Sisram Medical?
Sisram Medical's management team is headed by:
- Yi Liu - CHM
- Lior Moshe Dayan - CEO
- Guojun Bu - CFO
- Ran Ezioni - COO
- Doron Yannai - VFN
- Nadav Bayer - VPR
- Alexander Britva - VPR
- Yair Leopold - VPR
- Yosef Lepzelter - VPR
- Avraham Farbstein - OTH
- Fang Qianli - SEC
- Rongli Feng - NED
- Yao Wang - NED
- Yifang Wu - NED
- Chi Fung Chan - NID
- Jenny Chen - NID
- Heung Sang Fong - NID
- Kai Yu Liu - NID